Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-056879
Filing Date
2025-06-05
Accepted
2025-06-05 16:46:04
Documents
16
Effectiveness Date
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2517141d1_s8.htm S-8 62361
2 EXHIBIT 5.1 tm2517141d1_ex5-1.htm EX-5.1 11146
3 EXHIBIT 23.1 tm2517141d1_ex23-1.htm EX-23.1 2427
4 EXHIBIT 99.2 tm2517141d1_ex99-2.htm EX-99.2 142235
5 EX-FILING FEES tm2517141d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16482
6 GRAPHIC tm2517141d1_ex5-1img001.jpg GRAPHIC 5123
  Complete submission text file 0001104659-25-056879.txt   366174

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2517141d1_ex-filingfees_htm.xml XML 6802
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287807 | Film No.: 251027762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)